About us Contacts Drug interactions: 390 212
Drug search by name

Cometriq and Vitrakvi (Larotrectinib Oral Solution)

Determining the interaction of Cometriq and Vitrakvi (Larotrectinib Oral Solution) and the possibility of their joint administration.

Check result:
Cometriq <> Vitrakvi (Larotrectinib Oral Solution)
Relevance: 20.12.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Consumer information for this interaction is not currently available.MONITOR: Based on in vitro inhibition data, coadministration with cabozantinib may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is decreased clearance in the intestine, liver, and/or kidney due to inhibition of P-glycoprotein-mediated drug efflux by cabozantinib. MANAGEMENT: Caution is advised when cabozantinib is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever cabozantinib is added to or withdrawn from therapy. References "Product Information. Cometriq (cabozantinib)." Exelixis Inc, S San Francisco, CA.

Professional:

MONITOR: Based on in vitro inhibition data, coadministration with cabozantinib may increase the plasma concentrations of drugs that are substrates of the P-glycoprotein (P-gp) transporter. The proposed mechanism is decreased clearance in the intestine, liver, and/or kidney due to inhibition of P-glycoprotein-mediated drug efflux by cabozantinib.

MANAGEMENT: Caution is advised when cabozantinib is used concurrently with drugs that are known P-gp substrates, particularly those with a narrow therapeutic range. Dosage adjustments as well as clinical and laboratory monitoring may be appropriate for some drugs whenever cabozantinib is added to or withdrawn from therapy.

References
  • "Product Information. Cometriq (cabozantinib)." Exelixis Inc, S San Francisco, CA.
Cometriq

Generic Name: cabozantinib

Brand name: Cometriq, Cabometyx

Synonyms: n.a.

Vitrakvi (Larotrectinib Oral Solution)

Generic Name: larotrectinib

Brand name: Vitrakvi

Synonyms: Vitrakvi

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.